Live News REGULATION FLASH M impact Nov 18, 2026, 10:19 PM UTC FDA Approves Sanofi’s Infilbray for Gaucher Disease Type 3 Symptoms The FDA approved Sanofi’s Infilbray for neurological symptoms of Gaucher disease type 3. SquawkNews Desk